# Hangzhou Realy Tech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-realy-tech-co

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.realytech.com
- Latest round: Series B (Feb 24, 2018)
- Investors on record: 8

## About

Established in 2015 and based in Hangzhou, China, Hangzhou Realy Tech Co., Ltd. is a company that specializes in the POCT diagnostic kits and equipment through the operations of R&D, production and sales.

The company’s main business is the research, development, production, and sales of POCT diagnostic devices and reagents. The company’s self-developed products include a range of diagnostic platforms, such as the portable immunoassay analyzer RL-A2000, urinary microalbumin test kits, D-dimer test kits, and neutrophil gelatinase-associated lipocalin (NGAL) test kits.

The company generates revenue by providing POCT diagnostic solutions to healthcare providers, medical institutions and laboratories.

## Funding rounds

- Series B, Feb 24, 2018 — Taiheng Investment Management, Jisu Capital, Hangzhou Fenghui Liuheqiao Venture Capital Technology
- Series A, Mar 6, 2017 — YMC Investment, Beijing Danke Investment Management, Hangzhou Nimowan Investment Management
- Angel, Dec 31, 2015 — Haibang Venture, Jisu Capital, Yanhe Capital

## Investors

- Haibang Venture — Angel
- Jisu Capital (https://capitalatlas.ai/funds/jisu-capital) — Angel, Series B
- Yanhe Capital — Angel
- YMC Investment — Series A
- Beijing Danke Investment Management — Series A
- Hangzhou Nimowan Investment Management — Series A
- Taiheng Investment Management (https://capitalatlas.ai/funds/taiheng-investment-management) — Series B
- Hangzhou Fenghui Liuheqiao Venture Capital Technology — Series B